Immix Biopharma, Inc. is a biopharmaceutical company focused on developing tissue-specific therapeutics for cancer and immune-related diseases. They are currently working on clinical trials for soft tissue sarcoma, colorectal cancer, and multiple myeloma in collaboration with BeiGene Ltd.